MarketCap
Facebook
X
TelegramAnnual report 2023
added 12-27-2025
Profound Medical Corp. Accounts Receivables 2011-2026 | PROF
Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.Examples of accounts receivable
- Customers have not paid invoices for delivered products
- An advance has been paid to a supplier, but goods have not yet been received
- Employees have not reported on accountable amounts
- The government must refund tax overpayments
- Outstanding loans issued
- Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment. - Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages. - Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)
Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)
If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.
Quarterly Accounts Receivables Profound Medical Corp.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 17 K | - | - | - | 25 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 25 K | 17 K | 21 K |
Accounts Receivables of other stocks in the Medical devices industry
| Issuer | Accounts Receivables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abbott Laboratories
ABT
|
7.93 B | $ 102.87 | 0.48 % | $ 179 B |  USA |
 |
Align Technology
ALGN
|
996 M | $ 170.6 | -1.23 % | $ 12.8 B | USA |
 |
Apollo Endosurgery
APEN
|
15 M | - | - | $ 475 M | USA |
 |
Acutus Medical
AFIB
|
11.4 M | - | -26.83 % | $ 2.62 M | USA |
 |
Avinger
AVGR
|
1.01 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
44.8 M | - | - | $ 3.31 B | USA |
 |
Alphatec Holdings
ATEC
|
97.3 M | $ 10.83 | -3.82 % | $ 1.63 B | USA |
 |
Aziyo Biologics
AZYO
|
1.73 M | - | 1.37 % | $ 20.5 M | USA |
 |
Allied Healthcare Products
AHPI
|
2.37 M | - | 3.58 % | $ 2.21 M | USA |
 |
AxoGen
AXGN
|
26.2 M | $ 34.44 | 2.56 % | $ 1.59 B | USA |
 |
BioSig Technologies
BSGM
|
109 K | - | 37.08 % | $ 85.7 M | USA |
 |
ClearPoint Neuro
CLPT
|
6.55 M | $ 9.37 | 2.52 % | $ 265 M | USA |
 |
Accuray Incorporated
ARAY
|
83.2 M | $ 0.42 | 6.82 % | $ 43.2 M | USA |
 |
Cardiovascular Systems
CSII
|
39.7 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
43.1 M | - | -10.19 % | $ 1.99 M | USA |
 |
Cytosorbents Corporation
CTSO
|
7.55 M | $ 0.58 | 6.52 % | $ 36.1 M | USA |
 |
Delcath Systems
DCTH
|
11.7 M | $ 9.63 | 0.94 % | $ 345 M | USA |
 |
Dynatronics Corporation
DYNT
|
2.8 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
1.91 M | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
24.7 M | $ 23.29 | -1.52 % | $ 197 M | USA |
 |
Bruker Corporation
BRKR
|
566 M | $ 36.76 | 1.88 % | $ 5.48 K | USA |
 |
Conformis
CFMS
|
9.77 M | - | - | $ 16.4 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
660 M | $ 81.05 | -0.26 % | $ 47.4 B | USA |
 |
CONMED Corporation
CNMD
|
248 M | $ 34.79 | -2.08 % | $ 1.08 B | USA |
 |
Second Sight Medical Products
EYES
|
455 K | - | -0.97 % | $ 54.4 M | USA |
 |
Aethlon Medical
AEMD
|
128 K | $ 2.12 | -1.4 % | $ 3.31 M | USA |
 |
BIOLASE
BIOL
|
5.48 M | - | -13.19 % | $ 166 K | USA |
 |
AdaptHealth Corp.
AHCO
|
371 M | $ 12.03 | 1.43 % | $ 1.63 B | USA |
 |
Helius Medical Technologies
HSDT
|
117 K | $ 1.86 | 9.41 % | $ 1.13 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
272 M | $ 9.53 | -0.42 % | $ 734 M | USA |
 |
Inogen
INGN
|
38.9 M | $ 6.21 | -0.96 % | $ 165 M | USA |
 |
Inspire Medical Systems
INSP
|
120 M | $ 54.99 | 2.52 % | $ 1.61 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
53.8 M | $ 16.06 | -1.41 % | $ 377 M | USA |
 |
IRIDEX Corporation
IRIX
|
7.61 M | $ 0.98 | 3.17 % | $ 16.6 M | USA |
 |
Invacare Corporation
IVC
|
88 M | - | - | $ 24.7 M | USA |
 |
Integer Holdings Corporation
ITGR
|
346 M | $ 86.85 | 0.47 % | $ 3.02 B | USA |
 |
LivaNova PLC
LIVN
|
216 M | $ 63.79 | -1.3 % | $ 3.48 B |  Britain |
 |
LENSAR
LNSR
|
6.38 M | $ 6.06 | 1.51 % | $ 72.5 M | USA |